| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0007 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.47 | 0.002 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.096 | 0.006 |